Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-120288
Filing Date
2024-11-04
Accepted
2024-11-04 07:34:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 korrokeystoneprosuppregf.htm 424B3 83143
2 GRAPHIC img182136208_0.jpg GRAPHIC 2509
  Complete submission text file 0000950170-24-120288.txt   87886
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279402 | Film No.: 241420764
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)